GLP-1s Explained - Pharmaceutical Industry Trends

New type 2 diabetes and weight-loss drugs like Wegovy and Ozempic are transforming health care by helping users reduce blood sugar and lose significant weight, with potential revenue projected in the hundreds of billions. With high costs and limited insurance coverage, who will have access to these GLP-1 drugs? In this video, we’ll dive into the science, explore the hurdles relating to these novel drugs.

▶️ Watch our other videos: • Pharmaceutical Industry Overview - The Dru...

Key Sections
0:20 - Ozempic & Wegovy becoming billion dollar products
1:28 - How do GLP1s actually Work?
3:16 - The different types of these novel drugs: GLP-1 Agonists
4:05 - GLP-1 & GIP (Tirzepatide)
4:55 - The side effects of these drugs
5:07 - The cost concern
5:57 - The rise of non-approved alternatives (DIY PEPTIDES)

#glp1 #pharma #ozempic

📚 This video serves as an excerpt from the pharmaceutical industry Learning Primer, meticulously curated by the digital e-learning content provider, Primerli https://www.primerli.com/. The full module, comprising 10 bite-sized videos and quick quizzes, is tailored to empower professionals to grasp the industry intricacies in under an hour.

What industry do you want to learn about next? Let us know in the comments.

Enjoyed this video? Subscribe here: / @primerli

✅ Connect with us on LinkedIn: / primerli